Complex and Genetic Disease Research

Complex and Genetic Disease Research

Complex diseases are caused by a combination of genetic and environmental factors, many of which are not fully understood. Although some complex diseases can be highly heritable, many do not follow specific, clear models of inheritance and are not often the result of a single mutated gene. In fact, >90% of disease associated variants are located in non-coding regions of the genome.1 Roughly 5% of complex diseases are caused by monogenic inheritence, while the vast majority is polygenic.2 Autoimmune and rheumatic diseases, atherosclerosis and many forms of heart disease, neurological disorders, and psychiatric disorders are all types of disease that fall into this category.

Given their multifactorial nature, researching complex diseases has proven challenging. Luckily, genomics technologies, including arrays and next-generation sequencing (NGS), are helping accelerate research and are paving the way to achieve greater understanding of disease etiology and, hopefully one day, the diagnosis, treatment, and prevention of these diseases.

Featured Research Stories

How one children's hospital is transforming care for kids in Dubai
How one children's hospital is transforming care for kids in Dubai

Al Jalila Children's Specialty Hospital is on a mission to diagnose critically ill infants—and serve underrepresented patient populations

Read Article
Single-Cell Analysis is Advancing Insights in Developmental Biology
Single-Cell Analysis is Advancing Insights in Developmental Biology

A computer scientist transforms the world of biology by making bioinformatics tools available to all.

Read Interview
How indigenous scientists are taking control of their data
How indigenous scientists are taking control of their data

Next-generation sequencing is helping Native nations with sovereignty and genetic research

Read Article
See How Genomics Empowers Breakthroughs in Complex and Genetic Disease Research

Disease Association Studies

Genome-wide association studies uncover common and rare variants associated with disease

Gene Target Identification and Pathway Analysis

Differential Expression Analysis

Differential expression analysis measures changes in gene expression under different conditions or in response to determinite stimuli.

Expression Anaysis by RNA-Seq Provides:
  • Quantitative changes in expression across the transcriptome in different conditions
  • The ability to profile disease state changes and responses to therapeutics
Quantitative trait loci (QTL)

Quantitative trait loci (QTL) analysis identifies molecular markers that correlate to a quantitative change in a particular trait or dynamic outcome.

QTL Analysis Provides:
  • Immediate insight into a probable biological basis for disease associations
  • Identification of gene networks involved in disease pathogenesis
Epigenetic Analysis

Epigenetic analysis elucidates the biological mechanisms that alter gene activity resulting from non-coding variation and the environment.

Epigenomic Analysis Provides:
  • Insight into disease mechanisms for non-coding variants
  • A genome-wide view of changes and patterns in regulatory mechanisms

Polygenic Risk Scoring

A polygenic risk score represents an approximation of an individual’s genetic risk for disease, based on the sum of the risk alleles for a disease trait, relative to the population.

Polygenic risk scores have the potential to:
  • Stratify patients for clinical trials
  • Stratify samples for cohort analysis
  • Assess an individual’s heritable risk for disease
Interested in receiving newsletters, case studies, and information on complex disease genomics? Please enter your email address.